Search Results - "Baez De La Fuente, Enrique"

DNA damage in acute myeloid leukemia patients of Northern Mexico by Dávila-Rodríguez, Martha I, Cortés-Gutiérrez, Elva I, Hernández-Valdés, Roberto, Guzmán-Cortés, Karla, De León-Cantú, Rosa E, Cerda-Flores, Ricardo M, Báez-De la Fuente, Enrique

“…The purpose of this study was to evaluate DNA damage in the whole genome of peripheral blood leukocytes from patients with acute myeloid leukemia (AML)…”
Get full text

Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available by Foltz, Lynda, Pica, Gian-Matteo, Zerazhi, Hacene, Van Droogenbroeck, Jan, Visanica, Sorin, Báez de la Fuente, Enrique, Leber, Brian, de Almeida, Antonio Medina, Ranta, Dana, Kiladjian, Jean-Jacques, Chrit, Linda, Kandra, Albert, Morando, Juliane, Devos, Timothy

“…Ruxolitinib was recently approved for the treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea based on data from the…”
Get full text

Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas? by Ramirez Lopez, Alba Nydia, Baez De La Fuente, Enrique, De Leon Cantu, Rosa Elva, Cruz Contreras, Diego, Carrizalez Villarreal, Jose Alfredo, Cedillo De La Cerda, Jose Luis, Saldaña Vazquez, Roxana, Sorkee Davila, Helga Patricia, Rosas Rodríguez, Axel Eduardo, Baltazar Arellano, Severiano, Hernandez Valdes, Roberto, Lafarga Amao, Bernardo, Lozano, Rosa, Terrazas, Andrea

“…Diffuse large B-cell non-Hodgkin's lymphoma (NHL) is the most common High Grade Lymphoma obtaining complete responses up to 70% with chemotherapy (R-CHOP) 1…”
Get full text

Hematologic and molecular response with dasatinib as second-line treatment in chronic myeloid leukemia (CML) with treatment failure by Santos-Macías, Juan Enrique, Baez de la Fuente, Enrique, Salas-Delgado, Arnoldo

“…Chronic myeloid leukemia is a myeloproliferative disease characterized by the Philadelphia chromosome and with this, the chimeric protein BCR-ABL. The…”
Get full text

Updated Results from an Open-Label, Multicenter, Expanded Treatment Protocol (ETP) Phase (Ph) 3b Study of Ruxolitinib (RUX) in Patients (Pts) with Polycythemia Vera (PV) Who Were Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatment (Tx) Was Available by Foltz, Lynda, Pica, Gian-Matteo, Zerazhi, Hacene, Van Droogenbroeck, Jan, Visanica, Sorin, Báez de la Fuente, Enrique, Leber, Brian, de Almeida, Antonio Medina, Ranta, Dana, Cartes, Mauricio Reyes, Kiladjian, Jean-Jacques, Chrit, Linda, Yin, Zhaoyu, Morando, Juliane, Devos, Timothy

“…BACKGROUND Few Tx options are available for pts with inadequately controlled PV. European LeukemiaNet defined resistance/intolerance was seen in ≈25% pts…”
Get full text

Safety and Efficacy of Ruxolitinib (rux) in an Open-Label, Multicenter, Expanded Treatment Protocol in Patients (Pts) with Polycythemia Vera (PV) Who Are Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatments Are Available by Devos, Timothy, Pica, Gian Matteo, Zerazhi, Hacene, Van Droogenbroeck, Jan, Visanica, Sorin, Báez de la Fuente, Enrique, Leber, Brian, Almeida, Antonio Medina de, Ranta, Dana, Martinez, Tomasa, Kiladjian, Jean-Jacques, Chrit, Linda, Yin, Zhaoyu, Perez Ronco, Julian, Foltz, Lynda

“…BACKGROUND In the RESPONSE study, rux (a potent JAK1/2 inhibtor) has demonstrated superior response as compared to best available therapy (BAT) in controlling…”
Get full text

Pregnancy and myeloid leukemia treated with imatinib. Development and monitoring of a patient by Báez-de la Fuente, Enrique, Arellano-Severiano, Baltazar

“…Imatinib has changed the natural history of chronic myeloid leukemia. There are women with chronic myeloid leukemia in reproductive age with pregnancy desires…”
Get full text

Nilotinib in patients with chronic myeloid leukemia without response to imatinib by Báez-de la Fuente, Enrique, Arellano-Severiano, Baltazar

“…Resistance and intolerance to imatinib in patients with chronic myeloid leukemia requires alternative therapies. Nilotinib provides a choice as a second-line…”
Get more information

Secondary chromosomic changes in patients with chronic myeloid leukemia in a reference hospital in Northeastern Mexico by Dávila-Rodríguez, Martha I, Cerda-Flores, Ricardo M, Leal-Garza, Carlos H, Arana-Trejo, Rosa M, Báez-de la Fuente, Enrique, Cortés-Gutiérrez, Elva I

“…Our aim was to characterize the cytogenetic profile that displays a certain phase of chronic myelogenous leukemia (CML), offering new directions for…”
Get full text

Alteraciones cromosómicas secundarias en pacientes con leucemia mieloide crónica, en un hospital de referencia del noreste de México by Dávila-Rodríguez, Martha I., Cerda-Flores, Ricardo M., Leal-Garza, Carlos H., Arana-Trejo, Rosa M., Báez-de la Fuente, Enrique, Cortés-Gutiérrez, Elva I.

“…Introducción: la caracterización del perfil citogenético que presenta una determinada fase de la leucemia mieloide crónica (LMC), está ofreciendo nuevas…”
Get full text